E COLI VIRULENCE TRAITS IN INTRA-ABDOMINAL INFECTION
E COLI VIRULENCE TRAITS IN INTRA-ABDOMINAL INFECTION
批准号:
2064751
负责人:
TIMOTHY L PRUETT
金额:
$11.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-02-01 至 1995-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In spite of advances in surgical techniques, critical care facilities,
diagnostic capacities, and improvements in antimicrobial therapy, the
mortality from intraabdominal infection remains high. A recent experience
from five university intensive care units reported an overall mortality of
28% from intraabdominal infection. The magnitude of the clinical problem
necessitates continued basic research. The peritoneal cavity possesses a
remarkable capacity to combat infection. Surgical predecessors have laid
the groundwork of defining the mechanics whereby this region of the body
handles infection. These are typically described as: a) rapid dispersal
of particulate matter (including bacteria) via diaphragmatic lymphatics
lacunae; b) rapid upregulation of phagocytic capacity within the peritoneum
within 2-6 hours after bacterial introduction; and c) mechanical
sequestration of bacteria by fibrin trapping and obliteration of dead space
by paralytic ileus. An important consideration missing from the majority
of these studies is the alteration in outcome predicated upon rapid
adaptive changes of the infecting organisms. All bacteria do not possess
the same ability to produce infection and many can undergo significant
phenotypic changes in different environments. The specific aim of this
proposal is to understand how the most frequently recovered bacteria from
intraabdominal infection, Escherichia coli, evolves during peritoneal
infection. These organisms are not inert, but actively change their
metabolic pathways and physical properties to survive in a hostile
environment. The goals of the project are to determine: 1) the
intraperitoneal kinetics of varying wild types and laboratory strains of E.
coli, and correlate known virulence traits (O and K antigens,
alpha-hemolysin production, ability to adhere to mammalian cells, and the
expression of outer membrane proteins) to survivability within the
peritoneum. 2) the effect of adjuvants of intraperitoneal infection
(hemoglobin, bile salts, stool, mucin) upon the infectivity of E. coli and
correlation with virulence. 3) the traits of E. coli which promote mixed
infections: in particular with the most common anaerobe, Bacteroides
fragilis. An improved prognosis for patients with intraabdominal infection
will occur when physicians understand not only the manner in which the host
defenses interact with infecting organisms, but also the adaptive
mechanisms employed by the bacteria to survive within the host peritoneum.
It is the purpose of this proposal to begin the process of delineating
these mechanisms.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants.
使用基因工程溶血和非溶血大肠杆菌变体测定体内细胞因子对大肠杆菌α-溶血素的反应。
DOI:
10.1128/iai.64.6.2167-2171.1996
发表时间:
1996
期刊:
Infection and immunity
影响因子:
3.1
作者:
[May,AK, Sawyer,RG, Gleason,T, Whitworth,A, Pruett,TL]
通讯作者:
Pruett,TL
PHARMACOKINETICS OF ABBOTT CYCLOSPORINE FOLLOWING LIVER TRANSPLANT
-
批准号:6579037
-
项目类别:
-
资助金额:$4.85万
-
财政年份:2002
-
负责人:TIMOTHY L PRUETT
-
依托单位:
PHARMACOKINETIC COMPARISON OF NEORAL TO ABBOTT CYCLOSPORINE
-
批准号:6578935
-
项目类别:
-
资助金额:$4.85万
-
财政年份:2002
-
负责人:TIMOTHY L PRUETT
-
依托单位:
PHARMACOKINETICS OF ABBOTT CYCLOSPORINE FOLLOWING LIVER TRANSPLANT
-
批准号:6477564
-
项目类别:
-
资助金额:$4.85万
-
财政年份:2001
-
负责人:TIMOTHY L PRUETT
-
依托单位:
PHARMACOKINETIC COMPARISON OF NEORAL TO ABBOTT CYCLOSPORINE
-
批准号:6477462
-
项目类别:
-
资助金额:$4.85万
-
财政年份:2001
-
负责人:TIMOTHY L PRUETT
-
依托单位:
PHARMACOKINETIC COMPARISON OF NEORAL TO ABBOTT CYCLOSPORINE
-
批准号:6307416
-
项目类别:
-
资助金额:$2.81万
-
财政年份:1999
-
负责人:TIMOTHY L PRUETT
-
依托单位:
PHARMACOKINETIC COMPARISON OF NEORAL TO ABBOTT CYCLOSPORINE
-
批准号:6265268
-
项目类别:
-
资助金额:$2.81万
-
财政年份:1998
-
负责人:TIMOTHY L PRUETT
-
依托单位:
IV HBIG PHARMACOKINETIC STUDY
-
批准号:6279433
-
项目类别:
-
资助金额:$3.19万
-
财政年份:1997
-
负责人:TIMOTHY L PRUETT
-
依托单位:
SAFETY OF ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS DISEASE
-
批准号:6279423
-
项目类别:
-
资助金额:$3.19万
-
财政年份:1997
-
负责人:TIMOTHY L PRUETT
-
依托单位:
E COLI VIRULENCE TRAITS IN INTRAABDOMINAL INFECTION
-
批准号:3455409
-
项目类别:
-
资助金额:$10.85万
-
财政年份:1990
-
负责人:TIMOTHY L PRUETT
-
依托单位:
E COLI VIRULENCE TRAITS IN INTRAABDOMINAL INFECTION
-
批准号:3455408
-
项目类别:
-
资助金额:$10.67万
-
财政年份:1990
-
负责人:TIMOTHY L PRUETT
-
依托单位:
E COLI VIRULENCE TRAITS IN INTRAABDOMINAL INFECTION
-
批准号:3455410
-
项目类别:
-
资助金额:$11.32万
-
财政年份:1990
-
负责人:TIMOTHY L PRUETT
-
依托单位:
E COLI VIRULENCE TRAITS IN INTRAABDOMINAL INFECTION
-
批准号:3455411
-
项目类别:
-
资助金额:$11.62万
-
财政年份:1990
-
负责人:TIMOTHY L PRUETT
-
依托单位:
STUDY OF NEORAL VS SANDIMMUNE IN LIVER TRANSPLANTS
-
批准号:5221496
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:TIMOTHY L PRUETT
-
依托单位:--
SAFETY OF ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS DISEASE
-
批准号:6118228
-
项目类别:
-
资助金额:$3.03万
-
财政年份:--
-
负责人:TIMOTHY L PRUETT
-
依托单位:
IV HBIG PHARMACOKINETIC STUDY
-
批准号:6118238
-
项目类别:
-
资助金额:$3.03万
-
财政年份:--
-
负责人:TIMOTHY L PRUETT
-
依托单位:
SAFETY AND EFFICACY OF A NEW FORMULATION OF CYCLOSPORIN A
-
批准号:3765722
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:TIMOTHY L PRUETT
-
依托单位:
SAFETY OF ORAL GANCICLOVIR IN PREVENTION OF CYTOMEGALOVIRUS IN LIVER TRANSPLANTS
-
批准号:3743573
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:TIMOTHY L PRUETT
-
依托单位:
HEPATITIS B ANTIGEN/ANTIBODY LEVELS AFTER ORAL RIBAVIRIN
-
批准号:3787780
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:TIMOTHY L PRUETT
-
依托单位:
SAFETY OF ORAL GANCICLOVIR IN PREVENTION OF CYTOMEGALOVIRUS IN LIVER TRANSPLANTS
-
批准号:5221497
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:TIMOTHY L PRUETT
-
依托单位:--
PATHOGENESIS OF EXPERIMENTAL PERITONITIS & INTRA-ABDOMINAL ABCESSES
-
批准号:3890412
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:TIMOTHY L PRUETT
-
依托单位:
国内基金
海外基金
登录
查看更多内容
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
-
批准号:32302245
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:潘寒姁
-
依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
-
批准号:82371775
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:朱慧媛
-
依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
-
批准号:31871817
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:孙爱东
-
依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
-
批准号:81873549
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:刘玉兰
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
-
批准号:31571933
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:廖小军
-
依托单位:
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
-
批准号:31371861
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:江芸
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
-
批准号:31371845
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:廖小军
-
依托单位:
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
-
批准号:31171774
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2011
-
负责人:张德权
-
依托单位: